Dr. Jeff Geschwind is known for his extraordinary contributions to cancer research, including NIH-funded discoveries in tumor microenvironment imaging and new therapeutics targeting glycolysis. His roles across top institutions and industry partners demonstrate his influence in advancing precision oncology and groundbreaking liver cancer treatments. https://jeffgeschwind.com/honors/